Drag a card by its title · ⚙ to size, swap or remove

The company

ADARx Pharmaceuticals, Inc.

ADRX · Nasdaq

Health CareBiotechnology

We hold no 150-day reading for ADRX yet: it needs about 200 sessions of history. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: not in the set
Weeks in an uptrend: —
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $175.5M
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 0

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 0 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months6

Sale orders, 12 months0

Buyers · sellers6 · 0

Who	Did	Shares	Traded
Orbimed Advisors LlcDirector, 10% owner	bought	300,249at $17.00	28 Sep 2026filed 30 Sep 2026
Orbimed Advisors LlcDirector, 10% owner	bought	61,516at $17.00	28 Sep 2026filed 30 Sep 2026
Orbimed Advisors LlcDirector, 10% owner	bought	588,235at $17.00	28 Sep 2026filed 30 Sep 2026
Carl L. GordonDirector, 10% owner	bought	300,249at $17.00	28 Sep 2026filed 30 Sep 2026
Carl L. GordonDirector, 10% owner	bought	61,516at $17.00	28 Sep 2026filed 30 Sep 2026
Carl L. GordonDirector, 10% owner	bought	588,235at $17.00	28 Sep 2026filed 30 Sep 2026
Erez ChimovitsDirector	bought	61,516at $17.00	28 Sep 2026filed 30 Sep 2026
Simeon GeorgeDirector, 10% owner	bought	592,593at $17.00	28 Sep 2026filed 29 Sep 2026
Simeon GeorgeDirector, 10% owner	bought	414,814at $17.00	28 Sep 2026filed 29 Sep 2026
Simeon GeorgeDirector, 10% owner	bought	592,593at $17.00	28 Sep 2026filed 29 Sep 2026
Sr One Capital Management, Llc10% owner	bought	592,593at $17.00	28 Sep 2026filed 29 Sep 2026
Sr One Capital Management, Llc10% owner	bought	414,814at $17.00	28 Sep 2026filed 29 Sep 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders0

New · exited0 · 0

Reported value$0

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change

News

No headline names it lately.

Everyone who traded it

Carl L. Gordon Director, 10% owner · last 28 Sep 20261 · 0

Erez Chimovits Director · last 28 Sep 20261 · 0

LAV Biosciences Fund V, L.P. 10% owner · last 28 Sep 20260 · 0

Lav Fund Vi, L.p. 10% owner · last 28 Sep 20260 · 0

ORBIMED ADVISORS LLC Director, 10% owner · last 28 Sep 20261 · 0

Orbimed Genesis Gp Llc Director, 10% owner · last 28 Sep 20261 · 0

Simeon George Director, 10% owner · last 28 Sep 20261 · 0

SR ONE CAPITAL MANAGEMENT, LLC 10% owner · last 28 Sep 20261 · 0

Alan Robert MacLeod Chief Scientific Officer · last 24 Sep 20260 · 0

Robert William Ackles Chief People Officer · last 24 Sep 20260 · 0

Rui (nmn) Zhu Chief Technology Officer · last 24 Sep 20260 · 0

Ryan Fisk CFO and CBO · last 24 Sep 20260 · 0

Same industry

No other stock in its industry this week.

Government contracts

No federal award is tied to it.

From its SEC filings

No ratio computed from its SEC filings yet.

Analyst forecasts

No analyst forecasts yet.